Blavatnik Biomedical Accelerator

FUSION: A unique event for innovative leaders

Harvard’s FUSION symposium integrates perspectives from science and business to explore the promise of an emerging field. This annual, invite-only event brings together entrepreneurs, scientists, business leaders, investors, and innovators for an afternoon of exploration and networking. The FUSION symposium is jointly hosted by the Blavatnik Biomedical Accelerator (a program of Harvard University's Office of Technology Development) and by the Blavatnik Fellowship in Life Science Entrepreneurship at Harvard Business School.


  • FUSION 2016: A look back

    The 2016 Harvard FUSION symposium, a celebration of scientific advancement and economic development, explored the future of regenerative medicine and the business models that will bring life-changing innovations to patients.

    Watch the Highlights

2016 RECAP

Exploring the science and business of regenerative medicine

  • OPENING ADDRESS

    Lawrence H. Summers

    Charles W. Eliot University Professor and President Emeritus, Harvard University

  • PANEL DISCUSSION

    The Science

    What advances are at the leading edge of regenerative medicine today? What challenges remain for the field, and what areas of application have yet to be explored?

    Watch the video

  • PANEL DISCUSSION

    The Business

    Will new types of business models and organizational structures be needed to bring regenerative medicine products and services to patients?

    Watch the video

  • KEYNOTE ADDRESS

    Douglas A. Melton

    Xander University Professor and Thomas Dudley Cabot Professor in the Natural Sciences, Harvard University; co-director of the Harvard Stem Cell Institute; and scientific founder of Semma Therapeutics

    Watch the video

  • We know that science on its own can provide tremendous insights and improvements in the qualify of life.

    We also know that the marriage of science to real enterprise can create the infrastructure that brings society products of transformative value.

    Vicki L. Sato

    Professor of Management Practice, Harvard Business School

  • The knotty problem of bringing regenerative medicine to market

    When Lawrence Summers delivered his last commencement address as Harvard’s president 10 years ago, he spoke of the rosy future for stem cell science and regenerative medicine.

    The advancing technology, he said then, promised a cure for cancer, another for diabetes, a vaccine for Alzheimer’s disease, and ways to control AIDS, any one of which would have enormous impact around the world. Today, he believes he was too pessimistic...

    Read More
  • Harvard Gazette logo

Many thanks to our 2016 FUSION event sponsors

  • FUSION sponsor
  • FUSION sponsor
  • FUSION sponsor
  • FUSION sponsor
  • FUSION sponsor